These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1943438)

  • 1. Acute and long-term amphetamine treatments alter extracellular ascorbate in neostriatum but not nucleus accumbens of freely moving rats.
    Yount SE; Kraft ME; Pierce RC; Langley PE; Rebec GV
    Life Sci; 1991; 49(17):1237-44. PubMed ID: 1943438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine-, NMDA- and sigma-receptor antagonists exert differential effects on basal and amphetamine-induced changes in neostriatal ascorbate and DOPAC in awake, behaving rats.
    Pierce RC; Rebec GV
    Brain Res; 1992 May; 579(1):59-66. PubMed ID: 1352478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated treatment with ascorbate or haloperidol, but not clozapine, elevates extracellular ascorbate in the neostriatum of freely moving rats.
    Pierce RC; Clemens AJ; Shapiro LA; Rebec GV
    Psychopharmacology (Berl); 1994 Sep; 116(1):103-9. PubMed ID: 7862921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of direct and indirect dopamine agonists on brain extracellular ascorbate levels in the striatum and nucleus accumbens of awake rats.
    Phebus LA; Roush ME; Clemens JA
    Life Sci; 1990; 47(15):1317-23. PubMed ID: 1978214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ethanol on ascorbate release in the nucleus accumbens and striatum of freely moving rats.
    Svensson L; Wu C; Johannessen K; Engel JA
    Alcohol; 1992; 9(6):535-40. PubMed ID: 1361740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of both D1 and D2 dopamine receptors increases behavioral activation and ascorbate release in the neostriatum of freely moving rats.
    Pierce RC; Rebec GV
    Eur J Pharmacol; 1990 Dec; 191(3):295-302. PubMed ID: 1982267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crus cerebri lesions abolish amphetamine-induced ascorbate release in the rat neostriatum.
    Wilson RL; Kamata K; Bigelow JC; Rebec GV; Wightman RM
    Brain Res; 1986 Apr; 370(2):393-6. PubMed ID: 3518863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine promotes neostriatal ascorbate release via a nigro-thalamo-cortico-neostriatal loop.
    Pierce RC; Clemens AJ; Grabner CP; Rebec GV
    J Neurochem; 1994 Oct; 63(4):1499-507. PubMed ID: 7931303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of substance P on extracellular dopamine in neostriatum and nucleus accumbens.
    Boix F; Mattioli R; Adams F; Huston JP; Schwarting RK
    Eur J Pharmacol; 1992 May; 216(1):103-7. PubMed ID: 1382019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine enhances extracellular concentrations of dopamine and acetylcholine in dorsolateral striatum and nucleus accumbens of freely moving rats.
    Guix T; Hurd YL; Ungerstedt U
    Neurosci Lett; 1992 Apr; 138(1):137-40. PubMed ID: 1407652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrastriatal infusions of ascorbate antagonize the behavioral response to amphetamine.
    White LK; Maurer M; Kraft ME; Oh C; Rebec GV
    Pharmacol Biochem Behav; 1990 Jul; 36(3):485-9. PubMed ID: 2377651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shift from inhibition to excitation in the neostriatum but not in the nucleus accumbens following long-term amphetamine.
    Alloway KD; Rebec GV
    Brain Res; 1983 Aug; 273(1):71-9. PubMed ID: 6616234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    J Neurochem; 1992 Jun; 58(6):2285-91. PubMed ID: 1349347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Eur J Pharmacol; 1991 Mar; 195(1):63-73. PubMed ID: 2065713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral activation in rats requires endogenous ascorbate release in striatum.
    Rebec GV; Wang Z
    J Neurosci; 2001 Jan; 21(2):668-75. PubMed ID: 11160445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated administration of high doses of amphetamine increases release of ascorbic acid in caudate but not nucleus accumbens.
    Mueller K
    Brain Res; 1989 Aug; 494(1):30-5. PubMed ID: 2765922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of repeated amphetamine administration on the thyrotropin-releasing hormone level. Its release and receptors in the rat brain.
    Jaworska-Feil L; Budziszewska B; Lasón W
    Neuropeptides; 1995 Sep; 29(3):171-6. PubMed ID: 8538879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of haloperidol and amphetamine on ascorbic acid and uric acid in caudate and nucleus accumbens of rats as measured by voltammetry in vivo.
    Mueller K
    Life Sci; 1990; 47(8):735-42. PubMed ID: 2402194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple amphetamine injections reduce the release of ascorbic acid in the neostriatum of the rat.
    Kamata K; Wilson RL; Alloway KD; Rebec GV
    Brain Res; 1986 Jan; 362(2):331-8. PubMed ID: 3942882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.